International Journal of Radiation Oncology * Biology * Physics
Volume 75, Issue 3 , Pages 703-710 , 1 November 2009

Helical Tomotherapy for Simultaneous Multitarget Radiotherapy for Pulmonary Metastasis

  • Ji Yoon Kim, M.D.

      Affiliations

    • Department of Radiation Oncology, College of Medicine, The Catholic University of Korea, Seoul, Korea
    • ,
  • Chul Seung Kay, M.D.

      Affiliations

    • Department of Radiation Oncology, College of Medicine, The Catholic University of Korea, Seoul, Korea
    • Corresponding Author InformationReprint requests to: Chul-Seung Kay, M.D., Department of Radiation Oncology, Incheon St. Mary's Hospital, no. 665 Bupyeong6-dong Bupyeon-gu Incheon-si, South Korea. Tel: (82) 32-510-5078; Fax: (82) 32-510-5080
    • ,
  • Yeon Sil Kim, M.D.

      Affiliations

    • Department of Radiation Oncology, College of Medicine, The Catholic University of Korea, Seoul, Korea
    • ,
  • Jeong won Jang, M.D.

      Affiliations

    • Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea
    • ,
  • Si Hyun Bae, M.D.

      Affiliations

    • Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea
    • ,
  • Jong Yeong Choi, M.D.

      Affiliations

    • Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea
    • ,
  • Seung Kyu Yoon, M.D.

      Affiliations

    • Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea
    • ,
  • Ki Joon Kim, M.D.

      Affiliations

    • Department of Diagnostic Radiology, College of Medicine, The Catholic University of Korea, Seoul, Korea

Received 29 July 2008 ,Revised 13 November 2008 ,Accepted 14 November 2008.

References 

  1. Schrump DS, Altorki NK, Henschke CL, et al. Non-small cell lung cancer. In:  Devita VT,  Hellman S,  Rosenberg SA editor. Cancer: principles and practice of oncology. 7th ed. Philadelphia, PA: Lippincott; 2005;p. 753–810
  2. Timmerman RD, Kanavagh BD, Cho C, Papiez L, Xing L. Stereotactic body radiation therapy in multiple organ sites. J Clin Oncol. 2007;25:947–952
  3. Blomgren H, Lax I, Goranson H, et al. Radiosurgery for tumors in the body. Clinical experience using a new method. J Radiosurg. 1998;1:63–74
  4. Uematsu M, Shioda A, Tahara K, et al. Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients. Cancer. 1998;82:1062–1070
  5. Wulf J, Hadinger U, Oppitz U, et al. Stereotactic radiotherapy of targets in lung and liver. Strahlenther Onkol. 2001;177:645–655
  6. Nakagawa K, Aoki Y, Tago M, et al. Megavoltage CT-assisted stereotactic radiosurgery for thoraci tumors: Original research in the treatment of thoracic neoplasm. Int J Radiat Oncol Biol Phys. 2000;48:449–457
  7. Uematsu M, Shioda A, Suda A, et al. Computed tomography guided frameless stereotactic radiotherapy for Stage I non-small-cell lung cancer: A 5-year experience. Int J Raidat Oncol Biol Phys. 2001;51:666–670
  8. Nagata Y, Negoro Y, Aoki T, et al. Clinical outcome of 3D conformal hypofractionated single high dose radiotherapy for one or two lung tumors using a stereotactic body frame. Int J Radiat Oncol Biol Phys. 2002;52:1041–1046
  9. Hara R, Itami J, Kondo T, et al. Stereotactic single high dose irradiation for lung tumors under respiratory gating. Radiother Oncol. 2002;63:159–163
  10. Onimaru R, Shirato H, Shimizu S, et al. Tolerance of organs at risk in small volume, hypofractionated, image guided radiotherapy for primary and metastatic lung cancers. Int J Radiat Oncol Biol Phys. 2003;56:126–135
  11. Hof H, Herfarth KK, Munter M, et al. Stereotactic single dose radiotherapy of stage I non small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys. 2003;56:335–341
  12. Lee S, Choi E, Park H, et al. Stereotactic body frame based fractionated radiosurgery on consecutive days for primary or metastatic tumors in the lung. Lung Cancer. 2003;40:309–315
  13. Timmermann RD, Papiez L, McGarry R, et al. Extracranial stereotactic radioablation: Result of a phase I study in medically inoperable stage I non small cell lung cancer. Chest. 2003;124:1946–1955
  14. Wulf J, Haedinger U, Oppitz U, et al. Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: A noninvasive treatment approach in medically inoperable patients. Int J Radiat Oncol Biol Phys. 2004;60:186–196
  15. Mackie TR, Balog J, Ruchala K, et al. Tomotherapy. Semin Radiat Oncol. 1999;9:108–117
  16. Shi C, Penagaricano J, Papanikolaou N. Comparison of IMRT treatment plans between linac and helical tomotherapy based on integral dose and inhomogeniety index. Med Dosim. 2008;33:215–221
  17. Lee TF, Fang FM, Chao PJ, et al. Dosimetric comparison of helical tomotherapy and step-and-shoot intensity modulated radiotherapy in nasopharyngeal carcinoma. Radiother Oncol. 2008;89:89–96
  18. Miller KL, Shafman TD, Marks LB. A practical approach to pulmonary risk assessment in the radiotherapy of lung cancer. Semin Radiat Oncol. 2004;14:298–307
  19. Thrasse P, Arbuck SG, Eisenhauer EA, et al. New guidlines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst. 2000;92:205–216
  20. Hellmann S, Weichselbaum RR. Oligometastasis. J Clin Oncol. 1995;13:8–10
  21. Pastorino U, Buyse M, Friedel G, et al. Long term results of lung metastasectomy: prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg. 1997;113:37–349
  22. Okunieff P, Peterson AL, Philip A, et al. Stereotactic body radiation therapy for lung metastases. Acta Oncol. 2006;45:808–817
  23. Kavanagh BD, McGarry RC, Timmerman RD. Extracranial radiosurgery (stereotactic body radiation therapy) for oligometastasis. Semin Radiat Oncol. 2006;16:77–84
  24. Milano MT, Katz AW, Muhs AG, et al. A prospective pilot study of curative-intent stereotactic body radiotherapy in patients with 5 or fewer oligometastatic lesions. Cancer. 2008;112:658–658
  25. Okunieff P, Morgan D, Niemierko A, Suit H. Radiation dose response of human tumors. Int J Radiat Oncol Biol Phys. 1995;32:1227–1237
  26. Suit HD, Howes AE, Hynter N. Dependence of response of a C3H mammary carcinoma to fractionated irradiation on fractionation number and intertreatment interval. Radiat Res. 1977;70:440–454
  27. Hall EJ, Brenner DJ. The radiobiology of radiosurgery: Rationale for different treatment regimens for AVMs and malignancies. Int J Radiat Oncol Biol Phys. 1993;25:381–385
  28. Hall EJ, Giaccia AJ. Radiobiology for the radiologist. 6th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2006;
  29. Hernando M, Marks L, Bentel G, et al. Radiation-induced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancer. Int J Radiat Oncol Biol Phys. 2001;51:650–659
  30. Graham M, Purdy J, Emami B, et al. Clinical dose volume histogram analysis for pneumonitis after 3D treatment for non small cell lung cancer. Int J Radiat Oncol Biol Phys. 1999;45:323–329
  31. Kwa SLS, Theuws JCM, Wagenaar A, et al. Evaluation of two dose-volume histogram reduction models for the prediction of radiation pneumonitis. Radiother Oncol. 1998;48:61–69
  32. Marks LB. Dosimetric predictors of radiation induced lung injury. Int J Radiat Oncol Biol Phys. 2002;54:313–316

 Conflict of interest: none.

PII: S0360-3016(09)00196-5

doi: 10.1016/j.ijrobp.2008.11.065

International Journal of Radiation Oncology * Biology * Physics
Volume 75, Issue 3 , Pages 703-710 , 1 November 2009

Article Tools

* Image Usage & Resolution